LauraL.WorthMD
Pediatric Hematology & Oncology • Houston, TXAssociate Professor, University of Texas Medical School at Houston
Dr. Worth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd Unit 87
Houston, TX 77030Phone+1 713-792-7751Fax+1 713-794-5042- Is this information wrong?
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Pediatric Hematology/Oncology, 1994 - 1998- University of Texas Health Science Center at HoustonResidency, Pediatrics, 1990 - 1994
McGovern Medical School at UTHealthClass of 1990
Certifications & Licensure
TX State Medical License 1991 - 2025- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors Start of enrollment: 2005 Oct 01
- Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma Start of enrollment: 2007 Oct 01
- Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies Start of enrollment: 2009 Mar 02
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsOutcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes-T...Ossama M. Maher, Jorge Galvez Silva, Jimin Wu, Diane Liu, Laurence J.N. Cooper, Nidale Tarek, Laura L. Worth, Dean A. Lee, Demetrios Petropoulos, Anna Franklin, Patric...> ;Pediatric Transplantation. 2017 May 1
- 49 citationsFludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patientsBorje S. Andersson, Peter F. Thall, Ben C. Valdez, Denái R. Milton, Gheath Alatrash, J. Chen, Alison M. Gulbis, Diem T. Chu, Charles Martinez, Simrit Parmar, Uday R. P...> ;Bone Marrow Transplantation. 2017 Apr 1
- 72 citationsTreatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear CellsCharles S. Cox, Robert A. Hetz, George P. Liao, Benjamin M. Aertker, Linda Ewing-Cobbs, Jenifer Juranek, Sean I Savitz, Margaret L. Jackson, Anna Romanowska-Pawliczek,...> ;Stem Cells. 2017 Apr 1
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
